Related Experiment Video
Updated: Aug 13, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Disease severity and genotype-phenotype correlation in adult patients with familial Mediterranean fever
Fatma Tuncer Kuru1, Neslihan Gokcen1, Ayten Yazici1
1Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kocaeli University, Kocaeli, Turkey.
Objectives:
To assess the relationships of disease severity with genotype and phenotype in adult familial Mediterranean fever patients.
Methods:
Two-hundred seventy-five patients included in the study were divided into four groups according to their mutations: Group 1, M694V homozygous; Group 2, M694V-other; Group 3, other-other; and Group 4, no meaningful gene variants. Disease severity was evaluated using the Pras disease severity score. The association between Pras scores and other possible predictors was assessed by the multiple linear regression analysis.
Results:
In this study, 12.4% of all patients were in Group 1, 55.3% were in Group 2, 26.5% were in Group 3, and 5.8% were in Group 4. Pras scores were higher in Group 1 than in Groups 2, 3, and 4 (post hoc pairwise comparisons; P = .001, P < .001, and P = .001, respectively). Age at disease onset and age at diagnosis were found moderately and strongly correlated with Pras scores. Patients with moderate and severe disease were intensely involved in Group 1.
Conclusions:
Higher Pras scores, earlier age of symptoms and diagnosis, more frequent arthritis and erysipelas-like erythema, and higher colchicine dose are closely associated with M694V homozygous familial Mediterranean fever patients. These patients also have mostly moderate and severe disease severity.
Insights
Familial Mediterranean fever patients with the M694V homozygous genotype show higher disease severity scores. This genotype is linked to earlier symptom onset and more severe clinical manifestations.
Area of Science:
- Genetics
- Rheumatology
- Internal Medicine
Background:
- Familial Mediterranean fever (FMF) is an autoinflammatory disorder.
- Genetic mutations significantly influence FMF phenotype and disease severity.
- Understanding genotype-phenotype correlations is crucial for managing FMF.
Purpose of the Study:
- To investigate the relationship between disease severity and genetic mutations in adult FMF patients.
- To correlate specific genotypes with clinical phenotypes and disease severity scores.
Main Methods:
- 275 adult FMF patients were genotyped and categorized into four groups based on M694V mutation status.
- Disease severity was assessed using the Pras disease severity score.
- Multiple linear regression analysis was employed to evaluate associations.
Main Results:
- M694V homozygous patients (Group 1) exhibited significantly higher Pras scores compared to other groups.
- Age at disease onset and diagnosis strongly correlated with higher Pras scores.
- Moderate to severe disease was predominantly observed in the M694V homozygous group.
Conclusions:
- M694V homozygous genotype in FMF is associated with increased disease severity, earlier onset, and more frequent severe manifestations like arthritis.
- These findings highlight the importance of genotype in predicting FMF disease course and severity.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:18Genotype and Phenotype
Myocarditis II: Clinical Features and Diagnostic Tests
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pedigree Analysis
Cardiomyopathy III: Hypertrophic Cardiomyopathy